ArticleBMC pharmacology & toxicology2014

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.

Tharappel M Anil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.